Register now to learn about a new option for relapsed or refractory follicular lymphoma

CURE Magazine Hosts #CureConnect Tweet Chat on Women's Cancers

STAFF | September 14, 2018
CURE Media Group’s flagship product, CURE® magazine, the nation’s leading consumer digital and print media enterprise focused on patients with cancer, will host its monthly Tweet Chat on Thursday, September 27, at 1 p.m. EDT, for readers to ask questions and to facilitate discussions about women’s cancers.

“We look forward to hosting the next edition of the #CureConnect Tweet Chat on September 27, listening to stories and having opening discussions about women’s cancers,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group.

CURE® welcomes all patients and their loved ones, as well as health care professionals, advocates and nonprofit organizations, to join the chat on women’s cancers—vulvar, uterine, ovarian, breast, cervical and endometrial—by using the hashtag #CureConnect. Topics will include:
  • Fertility
  • Sex and intimacy
  • Body image
  • Early-age onset disease
  • Menopause and hormone therapy

For more information, visit or find us on Twitter @cure_magazine or on Facebook @curemagazine.

About CURE Media Group
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website,; innovative video programs, such as “CURE Connections®”; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers, as well as the dynamic website for oncology nurses,, and its companion, Oncology Nursing News® magazine. CURE Media Group is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® ( platform of resources for the practicing oncologist. For more information, visit or

External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.